After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board IRVINE, Calif., January 21, 2025--(BUSINESS WIRE)--Today the Board of Directors (the "Board") of Masimo (NASDAQ: MASI), a leading ...

Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointe ...

BTIG analyst Marie Thibault reiterated a Buy rating on Masimo (MASI – Research Report) today and set a price target of $178.00. The company’s ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $210.00. The ...

Masimo MASI-2.04%decrease; red down pointing triangle appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company’s founder. Szyman will become CEO of ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie ...

Masimo Corporation MASI announced preliminary revenues for the fourth quarter and full year 2024 on Thursday. Following the robust preliminary results, the company’s shares gained nearly 0.1% ...

Masimo and Apple are engaged in a legal battle over a patent dispute on the blood oxygen sensors in newer Apple Watch models, forcing the iPhone maker to sell the devices without the feature.

Masimo appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company's founder. Szyman will become CEO of the medical-device maker Feb. 12, replacing ...

Masimo and Apple are engaged in a legal battle over a patent dispute on the blood oxygen sensors in newer Apple Watch models, forcing the iPhone maker to sell the devices without the feature. Masimo ...